TKPHF:OTCMKTS
Takeda Pharmaceutical Co Ltd
$30.18
arrow_downward
-7.07%(-2.30) 1D
Jun 22, 4:00:00 PM GMT-4 · USD
search
All symbols
1D
5D
1M
6M
YTD
1Y
5Y
MAX
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for TKPHF...
Open
$30.18
High
$30.18
Low
$30.18
Mkt. cap
48.18B
Avg. vol.
6.93K
Volume
124.00
52-wk high
$39.20
52-wk low
$26.33
Beta
-1.14
Shares outstanding
1.59B
No. of employees
47K
Open
$30.18
High
$30.18
Low
$30.18
Mkt. cap
48.18B
Avg. vol.
6.93K
Volume
124.00
52-wk high
$39.20
52-wk low
$26.33
Beta
-1.14
Shares outstanding
1.59B
No. of employees
47K
News stories
From sources across the web
Simply Wall Street
·
16 hours ago
Takeda Pharmaceutical (TSE:4502) Stock Could Be 18.9% Undervalued After Phase 3 Drug Updates
Profile
The Takeda Pharmaceutical Company Limited is a Japanese multinational pharmaceutical company. It is the third largest pharmaceutical company in Asia, behind Sinopharm and Shanghai Pharmaceuticals, and one of the top 20 largest pharmaceutical companies in the world by revenue. The company has over 49,578 employees worldwide and achieved US$19.299 billion in revenue during the 2018 fiscal year. The company is focused on oncology, rare diseases, neuroscience, gastroenterology, plasma-derived therapies and vaccines. Its headquarters is located in Chuo-ku, Osaka, and it has an office in Nihonbashi, Chuo, Tokyo. In January 2012, Fortune Magazine ranked the Takeda Oncology Company as one of the 100 best companies to work for in the United States. As of 2015, Christophe Weber was appointed as the CEO and president of Takeda. In 2026, Julie Kim was noted in a news item as "CEO-elect". Wikipedia
About Takeda Pharmaceutical Co Ltd
CEOChristophe Weber | Christophe Weber
Employees47K
FoundedJun 12, 1781
Headquarters-
SectorPharmaceutical industry
Websitetakeda.com
AI content may include mistakes. Learn more